FDA Approved: DOXEPIN — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for the generic doxepin from Actavis Pharma, Inc., adding regulatory authorization for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Insomnia
• Major Depressive Disorder

Drugs mentioned

• Doxepin (Doxepin)

Snippet

SUPPL AP for DOXEPIN (DOXEPIN)